Cryogenic
Amsbio has published a new blog exploring why its CELLBANKER® cryopreservation solutions offer a safer, more consistent alternative to ‘homebrew’ cryopreservation media.
Homebrew formulations - typically a mix of DMSO, serum, and basal medium - are often chosen for their lower cost or lab-specific needs. However, their effectiveness can vary dramatically depending on the cell type, preparation method, and even serum batch. This variability can lead to inconsistent results, added validation work, and increased contamination risk.
CELLBANKER® takes the guesswork out of cryopreservation. Manufactured under strict quality controls using chemically defined, sterile components, it delivers reproducible performance every time. Ready-to-use and traceable, it removes in-lab mixing and reduces the risk of contamination, while supporting regulatory compliance and long-term sample integrity.
For sensitive cell types such as primary cells, iPSCs, or organoids, CELLBANKER® ensures higher post-thaw viability and reproducibility compared with serum-based homebrew media. Its GMP-grade formulations are also competitively priced, allowing researchers to adopt clinical-grade materials early in development without a costly transition later - simplifying validation and avoiding expensive requalification.
The blog features technical references and testimonials from internationally recognised organoid and stem cell research groups, highlighting real-world success with CELLBANKER®.
More information online
ILM Guide 2026/27